Schneider Jennifer
Schneider Jennifer, DIR, reported a transaction classified as grant at VERTEX PHARMACEUTICALS INC MA involving 472.000000 shares for an estimated $0.00. Reported holdings after the transaction were 2190.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 01, 2026
- Filing date
- May 05, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
VRTX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0000875320-26-000189 Common Stock
- Transaction date
- May 01, 2026 Filed May 05, 2026, 09:29 PM · 4d delay
- Shares
- 472 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 2,190 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
- F2
Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursu…
- F3
Fully vested.
- F4
Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a…
0 other transactions
0 recent txs